Concomitant Administration of VEGFR Tyrosine Kinase and Proton Pump Inhibitors May Impair Clinical Outcome of Patients With Metastatic Renal Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Concomitant Administration of VEGFR Tyrosine Kinase and Proton Pump Inhibitors May Impair Clinical Outcome of Patients With Metastatic Renal Cancer

Published:2024-06 Issue: Volume: Page:102147
ISSN:1558-7673
Container-title:Clinical Genitourinary Cancer
language:en
Short-container-title:Clinical Genitourinary Cancer

Author:

Del Re Marzia^ORCID,Crucitta Stefania^ORCID,Brighi Nicole,Kinspergher Stefania^ORCID,Mercinelli Chiara^ORCID,Rizzo Mimma^ORCID,Conteduca Vincenza^ORCID,Rebuzzi Sara Elena^ORCID,Beninato Teresa,Venturi Giulia,Doni Laura,Verzoni Elena,Puglisi Silvia,Landriscina Matteo,Porta Camillo,Manfredi Fiorella^ORCID,Caffo Orazio^ORCID,De Giorgi Ugo,Fogli Stefano,Danesi Romano

Funder

Università di Pisa

Ministero dell’Istruzione, dell’Università e della Ricerca

Publisher

Elsevier BV

Reference24 articles.

1. Drug absorption interactions between oral targeted anticancer agents and PPIs: is pH-dependent solubility the Achilles heel of targeted therapy?;Budha;Clin Pharmacol Ther,2012

2. Proton pump inhibitors and survival outcomes in patients with metastatic renal cell carcinoma;Lalani;Clin Genitourin Cancer,2017

3. Association of gastric acid suppression and sorafenib efficacy in advanced hepatocellular carcinoma;Razak;J Clin Gastroenterol,2021

4. Clinical pharmacokinetics and pharmacodynamics of pazopanib: towards optimized dosing;Verheijen;Clin Pharmacokinet,2017

5. The impact of a 1-hour time interval between pazopanib and subsequent intake of gastric acid suppressants on pazopanib exposure;Krens;Int J Cancer,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP